Europital has become a full service CRO
September 22, 2020
Ghent, Belgium: (September 22nd, 2020) Europital, a global provider of Medical Management services for the past 10 years, is pleased to announce that it has become a full-service CRO.
Since 2010, Europital has become well known and appreciated for its worldwide Medical Affairs services, and Europital is pleased to announce that it now has the capability to provide services across clinical operations, biostatistics, data management, pharmacovigilance and regulatory affairs. This expanded clinical research offering will see Europital support clients as a full service CRO in over 40 countries from IND through to commercial launch.
Europital is known to its clients in the pharmaceutical, biotechnology and medical device research sectors as a medically minded and scientifically driven company. Europital’s CMO, Dr. Mohamed El Malt, was keen to note that, “Although we have evolved from being a niche provider of Medical Management services to be able to offer the full range of services of a Contract Research Organization, we maintain the philosophy, ethic and driving force of Europital to put, not profit or expediency, but the scientific validity of study results and the safety of the patients first. These values have enabled us to have satisfied sponsors and a 100% repeat business rate.”
In pursuance of their objective to be a science driven CRO, Europital has put together a Scientific Board of experts who can provide their perspective and input to Sponsors’ projects. This undoubtedly provides an edge to the Sponsor’s product development and ultimate success as a safe, effective and practical solution to patients’ needs.
Europital is primarily staffed by physicians and has significant experience in the clinical development of treatments for complex oncology, infectious diseases, inflammatory and autoimmune disease indications. Innovators developing therapies in these areas will be the major beneficiaries of Europital’s multi-functional and operational capabilities. Sponsors who will particularly benefit are those that require a full range of CRO services for complex molecules and trial designs that necessitate senior medical and scientific oversight.
In addition to its regional offices in Europe, Europital has built a global network of trusted partners over the last 10 years with local operational expertise and preferential supply trial site agreements in the USA, Canada, Russia, India, the Middle East and North Africa and Australia.
“The decision to launch as a full-service CRO reflects the many requests we have had from our clients over the years to work on additional aspects of their clinical trials, but the services for which we did not have in-house. Now we can support them throughout the whole trial process. Our goal is to continue building our partnerships to become the leading science-based CRO for small to mid-sized pharma and biotech companies,” added Mohamed.
Europital is an international contract research organization (CRO), providing a full range of services for the clinical research and other drug and medical device development phases. We collaborate with sponsors in the pharmaceutical, biotechnology and medical device industries and for governmental and scientific Institutes.
With Europital’s scientific mindset, methodical approach and creative, science-driven solutions, each valued member of our Europital team is dedicated to deliver the highest quality services with a high sense of project ownership. Europital’s readiness, reliability and flexibility all mean we are committed to the success of clinical projects worldwide.
Contact Dave to learn how we can help with all your clinical research needs.
David Bruce MBA PhD
Business Development Manager
T: +44 (0) 1743 367696
M: +44 (0) 7850 123151
E: [email protected]